Guanfacine Hydrochloride Tablet, Extended Release shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2025-11-13 · last update 2025-11-13
Manufacturers: Actavis Pharma, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11) | Actavis Pharma, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 11/13/2025 Updated 11/13/2025 Discontinued 11/13/2025 |
| Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11) | Actavis Pharma, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 11/13/2025 Updated 11/13/2025 Discontinued 11/13/2025 |
| Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11) | Actavis Pharma, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 11/13/2025 Updated 11/13/2025 Discontinued 11/13/2025 |
| Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11) | Actavis Pharma, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted 11/13/2025 Updated 11/13/2025 Discontinued 11/13/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)